Phase II clinical trial of Niclosamide drug for treatment of COVID-19 patients begins Nation Phase II clinical trial of Niclosamide drug for treatment of COVID-19 patients begins News Analysis India 3 years ago By PTI NEW DELHI: The CSIR and Laxai Life Sciences Private Limited have initiated phase II clinical trials of anti-helminitic drug Niclosamide’ for the...Read More